Literature DB >> 31536760

Molecular mechanistic insights: The emerging role of SOXF transcription factors in tumorigenesis and development.

Yoshiki Higashijima1, Yasuharu Kanki2.   

Abstract

Over the last decade, the development and progress of next-generation sequencers incorporated with classical biochemical analyses have drastically produced novel insights into transcription factors, including Sry-like high-mobility group box (SOX) factors. In addition to their primary functions in binding to and activating specific downstream genes, transcription factors also participate in the dedifferentiation or direct reprogramming of somatic cells to undifferentiated cells or specific lineage cells. Since the discovery of SOX factors, members of the SOXF (SOX7, SOX17, and SOX18) family have been identified to play broad roles, especially with regard to cardiovascular development. More recently, SOXF factors have been recognized as crucial players in determining the cell fate and in the regulation of cancer cells. Here, we provide an overview of research on the mechanism by which SOXF factors regulate development and cancer, and discuss their potential as new targets for cancer drugs while offering insight into novel mechanistic transcriptional regulation during cell lineage commitment.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell differentiation; Development; SOXF; Transcription factor; Tumorigenesis

Year:  2019        PMID: 31536760     DOI: 10.1016/j.semcancer.2019.09.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  5 in total

1.  Bioinformatics analysis of SOXF family genes reveals potential regulatory mechanism and diagnostic value in cancers.

Authors:  Dan Wu; Chuan Jiang; Jing-Jing Zheng; De-Sheng Luo; Ji Ma; Hai-Feng Que; Chao Li; Chao Ma; Hui-Yong Wang; Wei Wang; Hong-Tao Xu
Journal:  Ann Transl Med       Date:  2022-06

2.  MET transcriptional regulator/serine peptidase inhibitor kunitz type 1 panel operating through HGF/c-MET axis as a prognostic signature in pan-cancer.

Authors:  Yi Xiang; Bishan Liang; Yu Jiang; Fei Sun; Yang Zhao; Qijing Wu; Xingbin Hu; Yajing Liu; Qiong Huang; Wangjun Liao; Zhiqi Yao; Shaowei Li; Min Shi
Journal:  Cancer Med       Date:  2021-03-09       Impact factor: 4.452

3.  Multi-Omics Analysis Reveals Novel Subtypes and Driver Genes in Glioblastoma.

Authors:  Yang Yuan; Pan Qi; Wang Xiang; Liu Yanhui; Li Yu; Mao Qing
Journal:  Front Genet       Date:  2020-11-26       Impact factor: 4.599

Review 4.  Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy.

Authors:  Xiangyuan Luo; Xiaoyu Ji; Meng Xie; Tongyue Zhang; Yijun Wang; Mengyu Sun; Wenjie Huang; Limin Xia
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

5.  The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC.

Authors:  Yan Shi; Meng-Yan Li; Hui Wang; Chao Li; Wen-Ying Liu; Yong-Mei Gao; Bo Wang; Jia-Wei Song; Yu-Qing Ma
Journal:  Anal Cell Pathol (Amst)       Date:  2022-02-22       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.